Laparoscopic Adjustable Gastric Banding in Adolescents
Study Details
Study Description
Brief Summary
This study is to determine if the Lap-band system is safe and effective for use in morbidly obese adolescents.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Gastric Banding Surgical placement of an adjustable gastric band around the upper portion of the stomach. Adjustments are made to the band through a subcutaneous port as needed to maintain appropriate restriction. |
Device: Adjustable Gastric Band
Surgical placement of an adjustable gastric band around the upper portion of the stomach.
Adjustments are made to the band through a subcutaneous port as needed to maintain appropriate restriction.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- weight loss [every 6 months for 5 years]
Secondary Outcome Measures
- The secondary objective is to assess the status of co-morbidities and changes in quality of life scores that occur in adolescents after surgical weight loss. [followed for 5 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
ages 14-17
-
BMI > 40
-
history of obesity for at least 5 years with failed attempts at diet and medical management for at least 6 months.
-
confirmation by a pediatric psychologist that the subject is sufficiently mature emotionally and has adequate family support to comply with the study protocol.
Exclusion Criteria:
-
history of congenital or acquired anomalies of the GI tract.
-
history of esophageal motility disorders
-
uncontrolled psychiatric problems
-
previous esophageal, gastric or bariatric surgery; intestinal obstruction or peritonitis.
-
uncontrolled eating disorders
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | A I duPont Hospital for Children/Nemours Children's Clinic | Wilmington | Delaware | United States | 19803 |
Sponsors and Collaborators
- Kirk Reichard
Investigators
- Principal Investigator: Kirk Reichard, MD, A I duPont Hospital for Children; Nemours Children's Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 0082295